indomethacin has been researched along with Deafness in 3 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
Deafness: A general term for the complete loss of the ability to hear from both ears.
Excerpt | Relevance | Reference |
---|---|---|
"The patients invariably developed chronic renal failure." | 1.31 | Hypokalemic salt-losing tubulopathy with chronic renal failure and sensorineural deafness. ( Henne, T; Jeck, N; Klaus, G; Konrad, M; Leonhardt, A; Mallmann, R; Marg, W; Pasel, K; Reinalter, SC; Seyberth, HW; Vollmer, M, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wickremasinghe, AC | 1 |
Rogers, EE | 1 |
Piecuch, RE | 1 |
Johnson, BC | 1 |
Golden, S | 1 |
Moon-Grady, AJ | 1 |
Clyman, RI | 1 |
Jeck, N | 1 |
Reinalter, SC | 1 |
Henne, T | 1 |
Marg, W | 1 |
Mallmann, R | 1 |
Pasel, K | 1 |
Vollmer, M | 1 |
Klaus, G | 1 |
Leonhardt, A | 1 |
Seyberth, HW | 1 |
Konrad, M | 1 |
Watson, PG | 1 |
Lobascher, D | 1 |
1 trial available for indomethacin and Deafness
Article | Year |
---|---|
The diagnosis and management of episcleritis and scleritis.
Topics: Arteritis; Arthritis, Rheumatoid; Behcet Syndrome; Clinical Trials as Topic; Deafness; Eczema; Epine | 1965 |
2 other studies available for indomethacin and Deafness
Article | Year |
---|---|
Neurodevelopmental outcomes following two different treatment approaches (early ligation and selective ligation) for patent ductus arteriosus.
Topics: Age Factors; Blindness; Cardiovascular Agents; Cerebral Palsy; Child, Preschool; Combined Modality T | 2012 |
Hypokalemic salt-losing tubulopathy with chronic renal failure and sensorineural deafness.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Bartter Syndrome; Child; Child, Preschool; Chro | 2001 |